Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Castello

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
BJU International|March 19, 2013
Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinomaMarianeve Polimeno, Maria Napolitano, Susan Costantini, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Journal of Translational Medicine|February 23, 2010
Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disordersLuigi Buonaguro, Annacarmen Petrizzo, Marialina Tornesello, et al.
Melanoma Research|December 4, 2003
Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21Milena Casula, Paolo A Ascierto, Antonio Cossu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studiesFrancesco Izzo, Paolo Marra, Gerardo Beneduce, et al.
Biogerontology|April 14, 2006
Multiple evidence for an early age pro-oxidant state in Down Syndrome patientsFederico V Pallardó, Paolo Degan, Marco d'Ischia, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migrationCaterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinomaEvan S Glazer, Mauro Piccirillo, Vittorio Albino, et al.
Free Radical Research|July 23, 2005
In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotesGiovanni Pagano, Adriana Zatterale, Paolo Degan, et al.
Plos One|September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesLuigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
BJU International|March 19, 2013
Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinomaMarianeve Polimeno, Maria Napolitano, Susan Costantini, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Journal of Translational Medicine|February 23, 2010
Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disordersLuigi Buonaguro, Annacarmen Petrizzo, Marialina Tornesello, et al.
Melanoma Research|December 4, 2003
Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21Milena Casula, Paolo A Ascierto, Antonio Cossu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studiesFrancesco Izzo, Paolo Marra, Gerardo Beneduce, et al.
Biogerontology|April 14, 2006
Multiple evidence for an early age pro-oxidant state in Down Syndrome patientsFederico V Pallardó, Paolo Degan, Marco d'Ischia, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migrationCaterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinomaEvan S Glazer, Mauro Piccirillo, Vittorio Albino, et al.
Free Radical Research|July 23, 2005
In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotesGiovanni Pagano, Adriana Zatterale, Paolo Degan, et al.
Plos One|September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesLuigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Pageof 9